Preference for a prefilled syringe or an autoinjection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study

Purpose: Simponi[R] (golimumab, MSD) is a fully human monoclonal antibody against tumor necrosis factor alpha administered subcutaneously using an autoinjector or a prefilled syringe. This study examined preference for administration of golimumab by autoinjector or prefilled syringe in patients with...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Patient preference and adherence 2018-01, Vol.12, p.1193
Hauptverfasser:	Vermeire, Severine, D'heygere, Frangois, Nakad, Antoine, Franchimont, Denis, Fontaine, Fernand, Louis, Edouard, Van Hootegem, Philippe, Dewit, Olivier, Lambrecht, Guy, Strubbe, Beatrijs, Baert, Filip
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Care and treatment Colitis Golimumab Labels Medical research Medical supplies Monoclonal antibodies Necrosis Patient compliance Syringes Tumor necrosis factor Tumors Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!